COTA Inc.
Cloud-based cancer outcomes tracking
This article was originally published in Start Up
Executive Summary
Cota Inc.’s COTA (Cancer Outcomes Tracking and Analysis) is a web-based analytics and database platform that allows oncologist service providers, as well as insurers and other payors, to track patients, spending, and clinical outcomes in real time. The system can sort clinical and cost outcomes to provide physicians with actionable data.
You may also be interested in...
Homology Medicines Inc.
Gene editing has made a great many headlines of late, and one could be forgiven for thinking the field was saturated, but Homology Medicines Inc. offers something new. Its platform relies on a different mechanism, known as homologous recombination, and the start-up's management team believes the approach can get around some of the potential limitations found in other gene-editing technologies.
X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc. spun out from Sanofi to develop compounds that target the CXCR4/CXCL12 receptor pathway to restore immune cell surveillance against cancer.
IO Combos By The Numbers
Over the past five years, pharma companies have cast an increasingly wide research net in search of cancer immunotherapy drug combinations that can help patients who have failed monotherapies.